igf-1 lr3 human study Recombinant (carrier-free), IGF-1 IGF-1 LR3 1mg - True

Every ingredient undergoes quality testing before the start of the manufacturing process, each batch of our supplement undergoes further rigorous quality testing

Trial Phase 1b (Lau et al., 2021) Phase 1b Duration 20 weeks Population (N) Multiple-ascending-dose study Key Result Cagrilintide half-life ~159195 hours

For optimal results, experts recommend a three-month course

lyogenix.com research use only Printed: 25/07/2026 For Research Use Only Not for Human Consumption This product is strictly intended for in-vitro research and laboratory use by qualified researchers

In one such study, adults with hyperthyroidism, largely from Graves disease, were given L-Carnitine supplementation over a 2-month time period